GUANTANAMO BAY, CUBA, December 10, 2025 /24-7PressRelease/ -- David Grote, a recognized global leader in biopharmaceutical quality assurance and operations, was selected for inclusion in Marquis Who's Who on October 10, 2025. His selection acknowledges his noteworthy accomplishments, visibility, and prominence across a career spanning more than 30 years.

Mr. Grote is currently driving strategy and innovation through two key ventures. As Vice President of Strategy at GrayMatter Partners (since 2025), he is instrumental in shaping organizational direction and driving strategic initiatives. Concurrently, as Principal Consultant and Founder of Curadian Group, he leverages his expertise to assist biopharma companies in transitioning products from discovery to approved medicines. His consultancy focuses on high-stakes, complex issues, including investigating and preventing manufacturing issues, regulatory agency inspections, warning letters, remediation, significant deviations, and recalls. He is also known for providing innovative solutions to the biopharmaceutical industry, leveraging advanced technologies such as artificial intelligence and hardware improvements (including instrumentation, valves, and equipment upgrades).

From 2021 to 2025, Mr. Grote served as Head of Quality at Immunocore, where he led GxP Quality for the global commercial and clinical biopharmaceutical company. He ensured all operations aligned with international regulatory standards by managing cross-functional quality teams and maintaining a robust quality management system (QMS). He was responsible for designing and implementing efficient systems for quality assurance, vendor oversight, audits, and training to maximize efficiency and minimize risk.

His tenure at Teva Pharmaceuticals from 2013 to 2021 marked a period of significant achievement. Serving as Global Head of Biologics Research and Development Quality Assurance (2015-2021) and previously as Head of Quality Assurance (2013-2015), he oversaw quality systems and regulatory compliance. His most notable accomplishment was facilitating the approval of Ajovy, a groundbreaking migraine medication. Mr. Grote was instrumental in resolving critical regulatory challenges; including addressing a United States Food and Drug Administration (FDA) warning letter received by the manufacturing partner; to ensure Ajovy was approved on schedule, ultimately improving the lives of patients worldwide.

Prior to his tenure at Teva Pharmaceuticals, Mr. Grote held several key positions at Amgen. In 2013, he served as senior specialist in operations regulatory compliance, following his role as senior manager of manufacturing from 2011 to 2013. From 2005 to 2011, he was senior manager of process validation and quality lead, and from 2002 to 2005, he contributed as validation lead. His early experience at Amgen began as a validation specialist at Immunex from 2001 to 2002, and before that at Valsource Inc. from 1999 to 2001. His foundational experience in the field was established as a validation engineer at Glaxo Wellcome Biopharmaceuticals from 1997 to 1999 and as a research biologist at Monsanto/Searle from 1993 to 1994.

In addition to his professional roles, Mr. Grote shared his expertise as a short course instructor with NC BioNetwork from 2009 to 2016, contributing to the education and development of future industry professionals. He is a respected member of several industry organizations, including the International Society of Pharmaceutical Engineers, the Military Spouse Employment Partnership and the Parenteral Drug Association.

Mr. Grote attributes his professional success to a strong technical foundation built on his Bachelor of Science in Biology from Truman State University (1993) and extensive graduate-level study in Biological Sciences at the University of Rhode Island.

Mr. Grote's dedication has been recognized with several awards, including the Eagle Scout distinction (1989), three ACES Awards from Amgen, and an award from Teva Pharmaceuticals.

Beyond his professional pursuits, he is an active volunteer, serving on the Parent Teacher Organization board and volunteering as a swim coach and with Scouting America. He enjoys a fulfilling personal life with his spouse, a U.S. Navy doctor, and their children, pursuing interests such as scuba diving, sailing, boating, and travel. Looking ahead, he remains committed to modernizing quality assurance and regulations in the pharmaceutical sector by incorporating new technologies and innovations.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #